Lurasidone is a medication used in the treatment of schizophrenia and bipolar depression. It is in the benzisothiazole class of medications. This activity describes the indications, action, and contraindications for lurasidone as a valuable agent in treating schizophrenia and bipolar depression. This activity will highlight the mechanism of action, adverse event profile, and other key factors, e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions pertinent for members of the interprofessional team in the treatment of patients with schizophrenia and bipolar depression.

**Objectives:**
- Outline the indications for lurasidone.
- Review the therapeutic dosing of lurasidone. 
- Identify the most common adverse effects of lurasidone therapy.
- Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by schizophrenia and bipolar depression.